3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Breast
1
Conditions
Breast Neoplasms
71
Neoplasms
64
Prostatic Neoplasms
45
Colorectal Neoplasms
41
Lung Neoplasms
37
Carcinoma, Non-Small-Cell Lung
26
Pancreatic Neoplasms
21
Neoplasm Metastasis
20
Hematologic Neoplasms
20
Head and Neck Neoplasms
19
Urinary Bladder Neoplasms
15
Ovarian Neoplasms
14
Multiple Myeloma
11
Motor Activity
11
Leukemia, Myeloid, Acute
11
Stomach Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Uterine Cervical Neoplasms
9
Triple Negative Breast Neoplasms
9
Glioblastoma
9
Colonic Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Glioma
8
Gastrointestinal Neoplasms
8
Carcinoma, Renal Cell
8
COVID-19
8
Anxiety Disorders
8
Anatomic Stage I Breast Cancer AJCC v8
8
Rectal Neoplasms
7
Melanoma
7
Interventions
Doxorubicin
18
Ifosfamide
13
Radiotherapy
8
Paclitaxel
7
pazopanib
6
pembrolizumab
4
Gemcitabine
4
Filgrastim
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
spartalizumab
3
durvalumab
3
Sorafenib
3
Propranolol
3
Nivolumab
3
Ipilimumab
3
Imatinib Mesylate
3
Etoposide
3
Epirubicin
3
Docetaxel
3
Carboplatin
3
trebananib
2
regorafenib
2
cixutumumab
2
cemiplimab
2
carotuximab
2
brostallicin
2
belinostat
2
balstilimab
2
Vincristine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Hemangiosarcoma
×
Standard of Care
×
Clear all
NCT01042379
2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled